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Abstract
Chromosome translocations induced by DNA damaging agents, such as ionizing radiation and certain chemotherapies, alter
genetic information resulting in malignant transformation. Abrogation or loss of the ataxia-telangiectasia mutated (ATM)
protein, a DNA damage signaling regulator, increases the incidence of chromosome translocations. However, how ATM
protects cells from chromosome translocations is still unclear. Chromosome translocations involving the MLL gene on
11q23 are the most frequent chromosome abnormalities in secondary leukemias associated with chemotherapy employing
etoposide, a topoisomerase II poison. Here we show that ATM deficiency results in the excessive binding of the DNA
recombination protein RAD51 at the translocation breakpoint hotspot of 11q23 chromosome translocation after etoposide
exposure. Binding of Replication protein A (RPA) and the chromatin remodeler INO80, which facilitate RAD51 loading on
damaged DNA, to the hotspot were also increased by ATM deficiency. Thus, in addition to activating DNA damage
signaling, ATM may avert chromosome translocations by preventing excessive loading of recombinational repair proteins
onto translocation breakpoint hotspots.
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Introduction
Recurring chromosome translocations are often associated with
specific types of leukemia/cancer and DNA damaging agents[1].
Breakpoints of these chromosome translocations have been shown
to cluster within restricted regions in or around the genes
implicated in the translocations. Chromosome translocations
involving 11q23 are one of the most common chromosome
abnormalities observed in secondary and infantile leukemias [2,3].
Among drugs used for anti-cancer chemotherapy, etoposide, a
topoisomerase II inhibitor, has been clearly associated with the
therapy-related leukemia carrying 11q23 chromosome transloca-
tions [4,5]. Most chromosomal translocation breakpoints in 11q23
are located within an 8.3-kb breakpoint cluster region (BCR)
spanning from exon 7 to 13 of the MLL gene [6,7]. However, how
etoposide induces 11q23 chromosome translocations in this region
is largely unknown [8].
DNA damage leads to activation of DNA damage response and
repair pathways. In normal cells, the ataxia-telangiectasia mutated
(ATM) protein regulates the DNA damage response in reaction to
DNA double-strand breaks (DSBs) through its kinase activity [9].
Altered function of ATM plays pathologic roles in the develop-
ment of leukemia/lymphoma and cancer including leukemia with
MLL translocations [10,11]. Moreover, an increase of 11q23
translocations is observed in an ATM kinase activity deficient
fibroblast cell line AT5BIVA [12]. Although these findings
indicate the involvement of ATM in chromosome translocations
involving 11q23, how ATM deficiency renders the BCR in the
MLL gene highly recombinogenic after etoposide treatment is still
unclear.
Homologous recombination (HR) is a versatile DNA repair
mechanism because it can promote the repair of a variety of
lesions including DSBs, single-strand gaps and stalled DNA
replication forks. RAD51 is one of the key proteins for DNA
repair by HR because it mediates homologous pairing and strand
exchange between DNA duplexes [13]. Interestingly, the elevated
RAD51 expression levels in tumor cells have been suggested to
contribute to genomic instability by stimulating aberrant recom-
bination between short repetitive elements and homologous
sequences [14,15,16]. Moreover, increased RAD51 expression
by introducing a RAD51 expression vector in a mouse embryonic
stem cell line promotes aneuploidy and chromosomal rearrange-
ment [17]. These findings suggest a link between increased levels
of RAD51 and chromosomal instability.
Here, we identified the BCR as the first native human
chromosomal DNA locus where RAD51, Replication protein A
(RPA) and INO80, a recombinational repair associated chromatin
remodeler [18], accumulate upon etoposide treatment. Impor-
tantly, ATM deficiency enhanced the etoposide-induced accumu-
lation of RAD51, RPA, and INO80 at the BCR. Thus, in addition
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to activating DNA damage signaling, ATM modulates the loading
of recombinational repair proteins onto translocation breakpoint
hotspots to avoid inappropriate recombination leading to
chromosome translocation.
Results
ATM and RAD51 are involved in 11q23 chromosomal
translocations
To examine the involvement of ATM kinase and recombination
proteins in 11q23 chromosomal translocations, we first analyzed
the rearrangement of the MLL gene after etoposide treatment in
ATM-deficient AT5BIVA cells and a clone of AT5BIVA
complemented with chromosome 11 (11-4), which carries the
ATM gene (Figure 1A). FISH analysis was performed using the 2-
color paired FISH probes located on either side of the MLL gene.
Since the paired probes span a genomic region of ,600 kb and
have little overlap, the MLL gene was most often detected as side-
by-side red and green signals of about 0.2 mm in diameter (Figure
S1). Therefore, when the centers of the red and green signals were
separated by.1 mm, we refer to their arrangement as a ‘split
signals’, which is indicative of a rearranged MLL gene (Figure 1B).
A significant increase in cells carrying split MLL gene signals at 6,
36 and 48 hours after etoposide exposure was observed when the
cells were ATM deficient and not when they were ATM proficient
(Figures 1B, C and S2). Moreover, treatment of 11-4 cells with
KU55933, a specific inhibitor of ATM kinase, increased the
incidence of 11-4 cells with the split signals after etoposide
treatment to the level comparable to that of BIVA cells (Figure 1C).
Apoptosis can potentially induce DNA breaks detected as a split
signals. However, there were actually less apoptotic cells in the
treated AT5BIVA cell population than in the 11-4 cell at 6 hours
after etoposide treatment (Figure S3). Furthermore, it is unlikely
that the split signals are due to DSBs ends that have become
untethered due to possible reduced function of Ku in AT5BIVA
cells compared to 11-4 cells, because immunoblotting and gel-shift
analyses showed no significant difference in the expression and
DNA binding activity of Ku80 between the cells (Figure S4).
Moreover, long distance inverse PCR analysis identified more
clones containing chromosome translocation breakpoints within
the BCR in AT5BIVA cells than in 11-4 cells (Figures S5).
Therefore, consistent with previous reports, these findings support
the notion that ATM deficiency increases 11q23 chromosome
translocations after etoposide exposure [12].
Since RAD51 overexpression has been implicated in chromo-
some translocations in general [17], we investigated whether
Figure 1. MLL rearrangement after etoposide treatment. (A) Schematic diagram of etoposide (VP) or Bleomycin (BLM) exposure and
subsequent culture for recovery. (B-D) Dual-color FISH analysis of AT5BIVA and 11-4 cells, cultured for 30 min (w30) and 6 hours (w6h) after
etoposide exposure (Con; unexposed cells). The cells were hybridized with paired probes spanning the MLL gene with overlap in the BCR
(centromeric side in green, telomeric side in red). (B) The representative images of FISH (BIVA w6h) are shown. Arrowheads indicate the split signals
(separated .1 mm). Scale bar: 5 mm. (C) The percentage of cells with split signals was significantly increased for AT5BIVA cells or the ATM kinase
inhibitor treated 11-4 cells compared to normal 11-4 cells cultured for 30 min (w30) or 6 hours (w6h) in normal medium after etoposide treatment
(*P,0.05, **P,0.0001 as determined by the Z test of homogeneity for independent samples, respectively). (D) 11-4 cells were transfected with a
RAD51 expression vector (RAD51) or an empty vector (mock). Twenty two hours after transfection, cells were treated with etoposide and cultured for
30 min (w30) and 6 hours (w6h) in normal medium (Con; unexposed cells). The percentage of cells with split signals was significantly higher in RAD51
overexpressing 11-4 cells compared to empty vector transfected cells after culturing for 30 min and 6 hours in normal medium (*P,0.01, **P,0.0001
as determined by the Z test).
doi:10.1371/journal.pone.0013554.g001
ATM Control HR Protein Binding
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increased RAD51 expression specifically promotes 11q23 chro-
mosome translocations. RAD51 expression levels were transiently
elevated by transfection of 11-4 cells with a human RAD51 cDNA
expression vector. We estimated the transfection efficiency at
approximately 44% as determined by immunofluorescence
analysis (Figure S6). Immunoblotting of whole-cell extracts
indicated an approximately 7-fold increase in the level of
RAD51 protein compared to extract from non-transfected cells.
We then analyzed the incidence of 11q23 chromosomal
translocations after etoposide treatment in 11-4 cells with
increased RAD51 expression. The percentage of cells carrying
split signals in the dual-color FISH analysis was significantly
increased in 11-4 cells overexpressing RAD51 after etoposide
treatment (Figure 1D). This finding suggests that increased
RAD51 expression facilitates 11q23 chromosomal translocations
after etoposide treatment. In contrast to ATM deficiency, RAD51
overexpression substantially increases the amount of RAD51 in
chromatin fraction (Figure S7). Therefore, the mechanisms for the
effects of RAD51 overexpression and ATM deficiency on 11q23
chromosome translocations could be different.
Loading of RAD51 onto the BCR after etoposide
treatment is modulated by ATM
Since increased levels of RAD51 promoted 11q23 chromosomal
translocations after etoposide treatment, we examined whether
etoposide treatment and/or ATM kinase activity affect RAD51
expression. Immunoblotting analysis of human lymphoid cell line
BV173, AT5BIVA and 11-4 cells showed that RAD51 expression
was not induced by etoposide treatment or ATM deficiency
(Figure 2A). RAD51 is also known to form nuclear foci after
induction of DNA damage by ionizing irradiation or certain
chemicals [19,20]. Immunofluorescence staining showed that after
etoposide treatment RAD51 foci positive cells increased to similar
levels in AT5BIVA, 11-4 and BV173 cells (Figures 2B and C).
These findings led us to speculate that RAD51 may be specifically
loaded on the BCR after etoposide exposure resulting in
illegitimate recombination leading to 11q23 translocation. If so,
RAD51 loading is predicted to be enhanced in the absence of
ATM activity because ATM-deficient cells display an increased
translocation frequency. To test this hypothesis, we examined the
recruitment of RAD51 to the BCR in AT5BIVA cells using
chromatin immunoprecipitation (ChIP) followed by real-time
polymerase chain reaction (PCR). We designed 6 primer sets (t2,
t4, bbt56, bt56, t56, in14) to analyze RAD51 binding in a region
around the approximately 20 base pairs (bps) translocation
breakpoint hotspot (Figure 3A and Figure S8) [4,5]. First, we
tested the amplification efficiency of DNA extracted from cells
after etoposide treatment by PCR. Real-time PCR analysis using
these 6 primer sets showed no significant differences in the
amplification efficiency of DNA extracted from cells before and
after etoposide treatment (Figure S9). ChIP analysis of BV173 and
11-4 cells using anti-RAD51 antibodies provided a hint that upon
etoposide treatment RAD51 accumulated to slightly higher levels
in the contiguous bt56 and t56 regions within the BCR compared
to adjacent regions and a control region in the b-globin gene locus
on chromosome 11p15 (Figures 3B and C). Interestingly, ChIP
analysis of AT5BIVA revealed that 30 min after recovery from
etoposide treatment RAD51 protein accumulated to significantly
higher levels in the bt56 and t56 regions within the BCR
compared to the closely located t2, t4 and in14 regions as well as
the b-globin control region (Figure 3D). Higher levels of the
RAD51 binding to the BCR in AT5BIVA cells could be observed
after treatment of cells with an increased dose of etoposide (Figure
S10). As a control we used bleomycin, a DNA damaging agent
that is not associated with 11q23 chromosome translocation. Like
etoposide, bleomycin induced RAD51 focus formation and did not
affect the expression of RAD51 (Figure 2B and Figure S11A).
However, compared with etoposide exposure, bleomycin treat-
ment did not result in a significant increase of RAD51 in the BCR
in 11-4 and AT5BIVA cells (Figures S11B and C).
Finally, treatment of 11-4 cells with the ATM kinase inhibitor
increased the binding of RAD51 to the BCR after etoposide
treatment (Figure S12). These findings indicate that kinase activity
of ATM is required for the proper regulation of the RAD51
binding to the BCR after etoposide treatment. Since ATM
deficiency and overexpression of RAD51 could enhance the effect
of etoposide to induce 11q23 chromosomal translocations,
aberrant binding of RAD51 to the BCR by ATM deficiency
may be responsible for the 11q23 chromosome translocations.
Binding of RPA to the BCR after etoposide treatment in
ATM deficient cells
Single-stranded DNA is the recombinogenic form of DNA onto
which RAD51 forms its active nucleoprotein filament that is
capable of engaging the partner DNA during HR. Once single-
stranded DNA is formed in cells in response to DNA damage, and
before formation of the RAD51 nucleoprotein filament, it is first
coated with replication protein A (RPA) [21,22]. Therefore, we
examined whether the binding of RPA to the BCR after etoposide
treatment differed in ATM-proficient versus ATM-deficient cells.
Interestingly, ChIP analysis of 11-4 cells, immediately after
etoposide removal, using anti-RPA antibodies revealed etopo-
side-induced enrichment of RPA in the BCR (Figure 4A). Since
the anti-RPA antibodies immunoprecipitates both phosphorylated
and non-phosphorylated forms of RPA (Figure S13), this result
indicates that RPA accumulates in the BCR as a consequence of
etoposide treatment. The ATM proficient 11-4 cells did recover
from the etoposide-induced insult because 30 min after recovery
from the exposure RPA levels returned to normal (Figure 4A). The
ATM deficient AT5BIVA cells also displayed an increase of RPA
bound to the BCR compared to the control region, but with two
noticeable differences (Figure 4B). First, RPA accumulation was
more extensive since it was observed in regions adjacent to bt56/
t56. Second, at 30 min after removal of the etoposide local RPA
levels remained high. Since the expression level of RPA was not
influenced by etoposide treatment or ATM kinase activity
(Figure 4C), ATM may control the appropriate loading and
release of RPA on damaged chromatin in the BCR after etoposide
treatment. These findings support the notion that ATM represses
the aberrant overloading of RPA, together with RAD51, on the
BCR after etoposide treatment by possibly promoting the recovery
of the etoposide-induced insult to DNA.
ATM regulates the binding of INO80 to the BCR
The INO80 chromatin remodeling complex has been implicat-
ed in the DNA damage response by facilitating single-stranded
DNA formation, a critical step in HR, and the displacement of
RPA with RAD51 in yeast cells [22,23,24]. Recently, INO80 has
been shown to play a role in mammalian HR [18]. Based on these
findings, we investigated the recruitment of INO80 to the BCR by
ChIP. Consistent with the notion that etoposide induces an
aberrant DNA structure in the BCR, resulting in a different
chromatin configuration as marked by increased RPA and RAD51
levels, the level of INO80 also increased in the BCR compared to
the control locus upon etoposide exposure (Figures 5A and B).
Importantly, in the absence of ATM activity there was a more
significant etoposide-induced enrichment of INO80 at the BCR
(Figure 5C). Since the expression of INO80 was regulated
ATM Control HR Protein Binding
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independently of ATM function and etoposide exposure (Figure 5D),
our findings suggest that ATM is required to properly regulate
RAD51-mediated DNA repair of etoposide-induced DNA damage
to which the BCR in the MLL locus is particularly susceptible and
that in its absence progression of repair stalls resulting in excessive
accumulation of INO80 and RAD51 on the BCR.
Discussion
In this study, we show that in the absence of ATM activity the
chromatin remodeler INO80, as well as the HR repair proteins
RPA and RAD51 accumulate at the BCR after etoposide
treatment. Since RAD51 makes DNA highly recombinogenic
[17,25], the aberrant loading of RAD51 on the BCR could
increase the recombinogenic activity of damaged chromatin within
the region. This may interfere with the normal repair process
resulting in the increased incidence of 11q23 chromosome
translocation in ATM kinase deficient cells.
ATM deficiencies increased the incidence of cells with the split
MLL gene signals in FISH analysis after etoposide treatment
(Figure 1C). The majority of the split FISH signals are most likely
due chromosome translocations, rather than persistent DSBs.
Since Ku, required for the tethering of DNA ends of DSBs, is
functional in AT5BIVA and 11-4 cells, we speculate that most of
the MLL gene rearrangements detected as split FISH signals are
chromosome translocations [26]. Because DSBs associated with
V(D)J recombination can persist in ATM deficient B cells [27], we
could not completely exclude the possibility that a fraction of the
rearrangement of the MLL gene detected as split MLL gene
signals are persistent DSBs, Importantly, these V(D)J recombina-
tion-associated DSBs in ATM deficient B cells participate in
chromosome translocations with other DSBs subsequently gener-
Figure 2. Focus formation and expression of RAD51 in ATM deficient cells. (A) Immunoblotting analysis of BV173, AT5BIVA and 11-4 cells
using an anti-RAD51 antibody. Cells were treated with etoposide (w30) or DMSO (Con) for 10 min and cultured for 30 min in normal medium. b-actin
was used as a loading control. (B) The percentage of RAD51 foci positive AT5BIVA, 11-4 and BV173 cells was significantly increased after etoposide or
bleomycin treatment (p,0.001, as determined by the Z test of homogeneity for independent samples). Values represent the means 6 SE from three
to four independent experiments (n.200 cells for each). (C) Focus formation of RAD51 in AT5BIVA and 11-4 cells after etoposide exposure. RAD51
nuclear foci were detected by immunofluorescence staining using anti-RAD51 antibodies. Scale bar: 5 mm.
doi:10.1371/journal.pone.0013554.g002
ATM Control HR Protein Binding
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ated by ionizing irradiation [27]. Taken together, these findings
further support the notion that ATM plays a role in the
suppression of 11q23 chromosome translocations after etoposide
treatment [12].
Classical nonhomologous DNA end-joining (NHEJ) has been
shown to play a role in chromosome translocations [1,28].
However, lymphomas with chromosome translocations are
observed in classical NHEJ-defective, ligase IV/XRCC4 deficient,
mice [29,30]. Therefore, the involvement of alternative NHEJ
processes, independent of ligase IV or XRCC4, has been also
suggested in chromosome translocations [31,32,33,34]. In the
absence ATM kinase activity, aberrant metabolism of damaged
DNA by recombinational repair proteins and chromatin remo-
delers might lead to alternative NHEJ processes resulting in 11q23
translocations after etoposide treatment. In replicating ATM
deficient cells, these alternative NHEJ processes might co-opt
activities of nucleases normally involved in replication and
recombination, such as CtIP and MRE11 [35], that could remove
the covalently bound topoisomerase II from the DNA break end
before it can be patched up by the end-joining process. Since
ATM deficiency increases the frequency of HR in mice and an
increase in chromosomal translocations is observed in ATM-
deficient cells [36,37,38], ATM may play a role in facilitating
classical and repressing alternative NHEJ and/or HR pathways
through the regulation of recombinational repair proteins and
chromatin remodelers.
Our observation that etoposide induces the transient binding of
RPA to the BCR suggests that this region is a specific target of
etoposide (Figure 4A and B) and that the etoposide-induced DNA
damage is processed into single-stranded DNA. RPA-single-
stranded DNA complexes are common intermediates in check-
point responses and DNA repair reactions [39]. The transient
etoposide-induced RPA binding to the BCR occurs in ATM-
proficient cells but in the absence of ATM it becomes more
prolonged and spreads out into adjacent regions of the BCR
(Figure 4A and B). This suggests that ATM is required to properly
enable timely DNA repair through the regulation of the RPA
binding. Recently, phosphorylation of RPA has been shown to
impede HR by repressing the loading of RAD51 in PP4
phosphatase deficient cells [40]. Therefore, increased binding of
hypophosphorylated RPA to the BCR after etoposide treatment
may lead to the aberrant RAD51 loading in ATM deficient cells.
We also show that the absence of ATM results in the excessive and
prolonged binding of INO80 to the bt56/t56 regions (Figure 5C).
Since INO80 exchanges RPA with RAD51 during HR, INO80,
together with RPA, could be responsible for the aberrant loading
of RAD51 [22].
We have identified the BCR in the MLL gene as the first native
human chromosomal DNA locus where recombination proteins
accumulate after induction of DNA damage by a specific DNA
damaging agent. Although the nature of DNA damage induced by
etoposide is still unclear, the BCR-specific DNA damage by
Figure 3. Binding of RAD51 to breakpoint clustering region in the MLL gene after etoposide treatment. (A) Schematic representation of
the BCR in the MLL gene. The arrow indicates the translocation breakpoint hotspot identified in treatment-related leukemias. Asterisks represent
topoisomerase II consensus sites. Positions of primer sets used in real-time PCR analysis (t2, t4, bbt56, bt56, t56 and in14) are indicated. (B-D) ChIP
analysis of BV173 (B), 11-4 (C) and AT5BIVA (D) cells was performed with anti-RAD51 antibodies, immediately after etoposide (VP), or vehicle (Con)
exposure, and 30 min after recovery in normal medium (w30). DNA was analyzed by real-time PCR using the primers indicated in (A) and that for a
control region in the b-globin gene (bG). Values represent the means 6 SE from five independent experiments. *: P,0.05 (compared to bG by
Student’s t test).
doi:10.1371/journal.pone.0013554.g003
ATM Control HR Protein Binding
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etoposide, such as replication fork collapse could be involved in
chromosome translocations. There were, however, no significant
differences in the BrdU incorporation after etoposide treatment
between the BCR and control beta-globin gene locus, suggesting
that the incidence of replication fork stalling could be similar in the
BCR and control locus (Figure S14). Therefore, ATM suppresses
the prolonged accumulation of recombination proteins and thus
our study suggests a mechanism through which the increased
frequency of chromosome translocations observed in cells from
AT patients occurs. DNA repair systems, especially HR, have
emerged as novel therapeutic targets in anti-cancer therapy [41].
Our study implies that inhibiting HR can have additional benefits
for an unexpected reason; the prevention of secondary malignan-
cies triggered by anti-cancer therapies.
Materials and Methods
Cell culture and chemical treatment
BV173, a human B cell line derived from CML, was cultured in
RPMI 1640 supplemented with 5% FBS. The SV40-transformed
AT fibroblast cell line AT5BIVA and its ATM-proficient
derivative, AT5BIVA cells reconstituted with chromosome 11
(11-4) [42], were kindly supplied by Dr. S. Matsuura. AT5BIVA
cells were cultured in DMEM supplemented with 10% FBS. 11-4
cells were maintained in DMEM supplemented with 10% FBS
and 0.2 mg/ml of G418. Cells were exposed to etoposide (Sigma,
St Louis, MO) at 100 mM for 10 min or bleomycin (WAKO) at
30 mg/ml for 60 min, respectively. Dimethylsulfoxide (DMSO)
was used as the vehicle for etoposide and was present in cell
cultures at the final concentration of 0.1%. Bleomycin was
dissolved in water. To inhibit ATM kinase activity, 11-4 cells were
treated with 10 mM of ATM kinase specific inhibitor KU55933 for
2 hours before etoposide treatment.
FISH analysis
FISH analysis was performed using LSI MLL Dual Color,
BreakApart Rearrangement Probe (Vysis, Abbott Molecular Inc,
IL, USA) according to the manufacturer’s protocol. Images were
acquired on a Zeiss AxioplanII microscope using an Axio-
CamMRm controlled by Axiovision. Subsequently, the cells
containing split signals of abnormalities in at least 200 of
etoposide-exposed or DMSO-exposed cells were counted. FISH
analyses were repeated three times.
Transient transfection of exogenous RAD51
Twenty-four hours before etoposide treatment AT5BIVA and
11-4 cells were transfected with the RAD51 expression vector
pcDNA3.1RAD51 using GeneJuice transfection reagent (Nova-
gen). The amount of expressed RAD51 was determined by
analyzing immunoblots using ImageJ. The transfection efficiency
was verified by calculating the percentage of flag-tag
pcDNA3.1RAD51 expressed cells after immunofluorescence
staining.
Figure 4. RPA is loaded on the BCR after etoposide treatment. (A, B) ChIP analysis after etoposide treatment of 11-4 (A) and AT5BIVA (B) cells
using antibodies against RPA was performed as described in Figure 3. Values represent the means 6 SE from three independent experiments.
*P,0.05 (compare to bG by Student’s t test). (C) Immunoblotting analysis of AT5BIVA and 11-4 cells using anti-RPA32 antibodies. Cells were treated
with etoposide for 10 min (VP) and allowed to recover in normal medium for 30 min (w30) or 2 hours (w2h). Slower migrating bands, indicated as
RPA32-P, in the long exposed blot were lost by l-phosphatase (lPPase) treatment. b-actin was used as a loading control.
doi:10.1371/journal.pone.0013554.g004
ATM Control HR Protein Binding
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Antibodies
The antibodies used for chromatin immunoprecipitation,
immunoblotting and immunofluorescence staining were anti-
RAD51 (Calbiochem), anti-RPA34 (LabVision), anti-glyceralde-
hyde-3-phosphate dehydrogenase (anti-GAPDH) (Santa Cruz),
anti-beta-actin (Sigma), anti-Flag M2 (Sigma), anti-RAD21
(Abcam), and anti-INO80 [43] antibodies.
Immunofluorescence staining
After fixation in 4% paraformaldehyde in 1x phosphate-
buffered saline (PBS) for 10 min at room temperature, cells were
permeabilized with 0.1% sodiumdodecyl sulfate (SDS)-0.5%
Triton X-100 in 1x PBS for 5 min [19]. For the detection of
RAD51 or Flag-tagged RAD51, fixed cells were incubated for
30 min at 37uC with anti-RAD51 antibody (1:1,000) or anti-Flag
M2 antibody (1:200) in 1% bovine serum albumin/1xPBS.
Fluorescein isothiocyanate (FITC)-conjugated goat anti-rabbit
(1:1,000, Biosource) antibodies was used as a secondary antibody.
Nuclei were stained with Hoechst 33342. Cells were mounted
using Vectashield and observed on an Axioplan2 microscope with
AxioCamMRm controlled by Axiovision software (Zeiss).
Primers
Primers for real-time PCR reactions were:
t2 forward: 59CCACCTTTACAATGAGGAAGGA39
t2 reverse: 59CCCGACGTGGATTTTCTTTA39,
t4 forward: 59TTTGAGAACAAGTTGCAGACA39
t4 reverse: 59GGGACAATTGGTCAAACCTA39
bbt56 forward: 59TGGAAAGGACAAACCAGACC39
bbt56 reverse: 59AGTATTGGACATTGCGGGAG39
bt56 forward: 59TACTCTGAATCTCCCGCA39
bt56 reverse: 59CGCTCGTTCTCCTCTAA39
t56 forward: 59TTGCCAAGTCTGTTGTGAGC39
t56 reverse: 59CAGAGGCCCAGCTGTAGTTC39
in14 forward: 59GGTTCCCAACATATGGCTTT39
in14 reverse: 59GCCGCTCAGTACAGTTCACA39
bG forward: 59TTGGACCCAGAGGTTCTTTG39
bG reverse: 59GAGCCAGGCCATCACTAAAG39
Chromatin immunoprecipitation and real-time PCR assay
Chromatin immunoprecipitation was performed as described
previously [44]. In brief, cells were fixed by adding formaldehyde
to 1% final concentration for 10 min at room temperature. Cells
were then sonicated to prepare chromatin suspensions of roughly
300–500 bps DNA in length. Immunoprecipitations were carried
out using antibodies described in Methods. Normal rabbit/mouse
IgG was used as a negative control. Real-time PCR reactions were
carried out using LightCycle (Fast Start DNA Master SYBR
GREEN 1, Roche or SYBR premix Ex Taq, TAKARA). Primers
for real-time PCR were as described above. Dissociation curve
analysis of the amplified DNA melting temperature showed that
each primer set gave a single and specific product. The
Figure 5. INO80 loading on the BCR after etoposide treatment. (A-C) ChIP analysis of BV173 (A), 11-4 (B) and AT5BIVA (C) cells after
etoposide exposure was performed with antibodies against INO80 as described in Figure 3. Values are the means 6 SE from three independent
experiments. (D) Immunoblotting analysis of BV173, AT5BIVA and 11-4 cells was performed using anti-INO80 antibodies. RAD21 was used as a
loading control. * P,0.05 (compared to bG by Student’s t test).
doi:10.1371/journal.pone.0013554.g005
ATM Control HR Protein Binding
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immunoprecipitation data were normalized to that of a control
region in the b-globin gene (bG) to correct for experimental
variation. The relative immunoprecipitation value represents the
ratio of immunoprecipitated DNA after chemical treatment to
immunoprecipitated DNA after vehicle treatment. All ChIP
analyses were repeated at least three times and, in each
experiment, quantitative PCR reactions were done in duplicate.
Values represent the mean 6 SE.
Immunoblotting analyses
Cells were treated with etoposide, bleomycin or left untreated,
unless stated otherwise. For immunoblotting analysis, samples
were separated by SDS-PAGE, transferred to a PVDF membrane,
and detected with antibodies against RAD51, RPA, INO80 and
loading control proteins.
Annexin V apoptosis assay
AT5BIVA and 11-4 cells were treated with vehicle (Con) or
etoposide and allowed to recover in normal medium for 30 min
(w30) and 6 hours (w6h). The Annexin V Apoptosis Assay was
performed using Annexin V : PE Apoptosis Detection Kit
according to the manufacturer’s protocol and analyzed by flow
cytometry (BD). Cells undergoing apoptosis were quantified as a
percentage of total cells.
Chromatin fraction preparation
Cells were collected, washed with phosphate-buffered saline
(PBS) and resuspended in hypotonic buffer (10 mM Tris-HCl
(pH 7.3), 10 mM KCl, 3 mM MgCl2). Briefly, cells were
homogenized and vortexed before centrifuged for 5 min at 2,
900 rpm. The nuclear pellet was subsequently lysed with Low
buffer (20 mM Tris-HCl (pH 7.3), 1.5 mM MgCl2, 0.02 M KCl,
25% glycerol) and High buffer (20 mM Tris-HCl (pH 7.3),
1.5 mM MgCl2, 1.2 M KCl, 25% glycerol). After rotation
60 min at 4uC, centrifuged for 14,000 rpm30 min. The insoluble
chromatin pellet was sonicated in TGME buffer (50 mM Tris-HCl
(pH 8.0), 5 mM MgCl2, 0.05 mM KCl, 25% glycerol).
Long-distance inverse PCR (LDI-PCR)
Genomic DNA isolated from BIVA and 11-4# cells was
digested with restriction enzyme BamHI (TOYOBO). Digested
genomic DNA (2 mg) were self-ligated at 16uC for 24 hours using
T4 DNA ligase (NEB). Subsequently, LDI-PCR reactions were
performed using TaKaRa LA taq DNA polymerase (TAKARA).
First round PCR conditions were 93uC 3 min; 10 cycles at 93uC
15sec, 60uC 30sec, and 68uC 8 min; 15 cycles at 93uC 15sec,
60uC 30sec. and 68uC 8 min (+20sec/cycle), 68uC 10 min.
Second round nested PCR conditions were 93uC 3 min; 10 cycles
at 93uC 15sec, 68uC 8 min; 20 cycles at 93uC 15sec, 60uC 30sec.
and 68uC 8 min (+20sec/cycle); 68uC 10 min. PCR products
were separated on 0.8% agarose gels. Non-germ-line DNA
amplimers were gel extracted and sequenced directly. Primers for
PCR were, (59-39)
1, GACATTCCCTTCTTCACTCTTTTCCTC
2, GCAGCCTCCACCACCAGAATCAGGTGAGTG
3, FTTTCGTGGAGGAGGCTCACTACTG
4, CAGCCTGGGTGACAAAGCAAAACAC
5, CCCATTAGCAGGTGGGTTTA
6, GAGGATCACGAGCCCACAAGGTCTA
7, AACCCTGCCCACTTGCCATTTGAAG
8, TTTGAGAACAAGTTGCAGACA
9, CCCACCCCACTCCTTTATATTCCCATAG
Eletrophoretic mobility shift assay
Non-isotopic electrophoresis mobility shift assay was performed
using nuclear extracts of AT5BIVA and 11-4 cells. The 56-bp
dsDNA (59-GATCAGTGATGGAGTTGGCCACTCCCTCTC-
TGCGCGCTCGCTCGCTCACTGAGGCC-39) was end la-
beled with using DIG-11-ddUTP (Roche) [45]. DNA end-binding
reaction and detection were performed according to the
manufacturer’s protocol (Roche). The DNA end-binding reactions
were separated on 5% polyacrylamide gels. For the supershifts, the
specific antibodies to Ku80 (Cell signaling) were added to the
reaction mixture and incubated for 30 minutes before separating
the DNA-protein complexes. Unlabeled dsDNA was used as
specific competitor.
Quantitative analysis of BrdU incorporation
Etoposide treated AT5BIVA and 11-4 cells were wash out and
culture in 10 mM of BrdU containing or BrdU free medium for
60 min. Cells were sonicated to prepare chromatin suspensions of
roughly 300–500 bps DNA in length. Chromatin fraction was
treated by proteinase K and extracted with phenol/chloroform.
Immunoprecipitations were carried out using antibodies against
normal IgG or BrdU (Roche) after genomic DNA was denatured
in boiling water for 10 min. Quantitative analysis of immunopre-
cipitated DNA was performed as described above.
Supporting Information
Figure S1 Scheme of fluorescent probes for the 11q23 locus
specific identifier (LSI). The maximal size of the overlap of the two
contigs between exons 7 and 13 is 7.4 kb. Centromeric to the MLL
breakpoint region is the 350-400 kb green probe and mostly
telomeric to the BCR region is the 190 kb orange probe.
Found at: doi:10.1371/journal.pone.0013554.s001 (0.15 MB TIF)
Figure S2 Dual-color FISH analysis of AT5BIVA and 11-4 cells.
Cells were cultured for 36 hours (w36h) and 48 hours (w48h) in
normal medium after etoposide treatment (Con; unexposed cells).
The split signals (separated .1 mm) were counted from 200 cells.
The experiments were performed three times (*P,0.001 as
determined by the Z test of homogeneity for independent samples).
Found at: doi:10.1371/journal.pone.0013554.s002 (0.17 MB TIF)
Figure S3 Analysis of apoptotic cells after etoposide treatment.
AT5BIVA and 11-4 cells were treated with vehicle (Con) or
etoposide and allowed to recover in normal medium for 30 min
(w30) and 6 hours (w6h). Cells were incubated with Annexin V-PE
in a buffer containing 7-Amino-actinomycin (7-AAD) and
analyzed by flow cytometry. Cells undergoing apoptosis were
quantified as a percentage of total cells.
Found at: doi:10.1371/journal.pone.0013554.s003 (0.38 MB TIF)
Figure S4 The expression level and DNA binding activity of
Ku80. (A) Immunoblotting analysis of Ku80 using anti-Ku80
antibodies. (B) DNA end-binding activity of Ku70/80. Non-
isotopic electrophoretic mobility shift assay was performed using
nuclear extracts of AT5BIVA and 11-4 cells. Lane 1: BIVA; Lane
2: BIVA + anti-Ku80; Lane 3: 11-4; Lane 4: 11-4 + anti-Ku80;
Lane 5: unlabeled specific probe.
Found at: doi:10.1371/journal.pone.0013554.s004 (0.81 MB TIF)
Figure S5 Summary of etoposide induced breakpoints within
MLL BCR. (A) LDI (Long Distance Inverse) PCR was performed
using BamHI digested genomic DNA. (B) The spectrum of
etoposide-induced MLL gene repair products. Before isolating
genomic DNA, AT5BIVA and 11-4 cells were treated with
100 mM of etoposide for 10 min and allowed to recover for 6 or 24
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hours in normal medium. (C) The sequence of breakpoint
junctions. Black: MLL gene; Blue: partner gene; Red: micro-
homology sequence between MLL gene and fusion partner gene.
Found at: doi:10.1371/journal.pone.0013554.s005 (0.71 MB TIF)
Figure S6 The expression of exogenous RAD51. 11-4 cells were
transfected with pcDNA3.1flagRAD51expression plasmid for 24
hours. Immunofluorescence staining was performed with anti-Flag
M2 antibodies. Blue: DNA, Red: flagRAD51. Scale bar: 20 mm.
Found at: doi:10.1371/journal.pone.0013554.s006 (1.54 MB TIF)
Figure S7 Immunoblotting analysis of RAD51 overexpressing
cells. Chromatin fraction (Chr.f) and whole cell extracts (WCE)
were isolated from 100 mM of etoposide (VP), or vehicle (Con)
treated cells. AT5BIVA and 11-4 cells were transfected with an
empty expression vector (mock) or RAD51 expression vector
(RAD51) for 24 hours before etoposide treatment.
Found at: doi:10.1371/journal.pone.0013554.s007 (0.31 MB TIF)
Figure S8 Translocation breakpoint hotspot in the BCR. The
chromosomal translocation breakpoint hotspot is shown in red.
Boxes indicate the presumed topoisomerase II binding sites.
Arrows indicate primer sets (t4, bbt56, bt56 and t56) used for real-
time PCR.
Found at: doi:10.1371/journal.pone.0013554.s008 (0.65 MB TIF)
Figure S9 Amplification efficiency of genomic DNA by PCR.
Real-time PCR analysis of genomic DNA extracted from
AT5BIVA, 11-4 and BV173 cells using the primers indicated in
Figure 3A and the Methods. Values represent the means+/-SE
from three independent experiments.
Found at: doi:10.1371/journal.pone.0013554.s009 (0.27 MB TIF)
Figure S10 Binding of RAD51 to BCR in the MLL gene after a
high dose of etoposide. ChIP analysis of AT5BIVA and 11-4 cells
was performed with anti-RAD51 antibodies, immediately after
300 mM of etoposide (VP), or vehicle (Con) exposure, and 30 min
after recovery in normal medium (w30). DNA was analyzed by
real-time PCR using the primers indicated in Figure 3A and the
Methods. Values represent the means+/-SE from three indepen-
dent experiments. Asterisks represent P,0.05 (compared to b-
globin by Student’s t test).
Found at: doi:10.1371/journal.pone.0013554.s010 (0.25 MB TIF)
Figure S11 Binding of RAD51 to breakpoint clustering region
in the MLL gene after bleomycin treatment. (A) RAD51
expression after etoposide or bleomycin treatment. Immunoblot-
ting analysis of BV173 cells using the anti-RAD51 antibody.
BV173 cells were treated with etoposide at 100 (100) or 120
(120) mM for 10 min, or bleomycin at 30 mg/ml for 60 min (BLM),
and allowed to recover in normal medium for 30 min (100w,
120w, 30w). GAPDH was used as a loading control. (B, C) ChIP
analysis after bleomycin treatment of 11-4 (B) and AT5BIVA (C)
cells using anti-RAD51 antibodies, immediately after bleomycin at
30 mg/ml for 60 min (BLM), or vehicle (Con) exposure, and 30
min after recovery in normal medium (w30).
Found at: doi:10.1371/journal.pone.0013554.s011 (0.28 MB TIF)
Figure S12 Binding of RAD51 to BCR in the MLL gene after
ATM inhibitor treatment. Following treatment of cells with
10 mM of ATM inhibitor (KU55933) for 2 hours, ChIP analysis of
11-4 cells was performed with anti-RAD51 antibodies, immedi-
ately after etoposide (VP), or vehicle (Con) exposure, and 30 min
after recovery in normal medium (w30), DNA was analyzed by
real-time PCR. Values represent the ratio of enrichment of
RAD51 in ATM inhibitor treated cells to untreated cells.
Found at: doi:10.1371/journal.pone.0013554.s012 (0.19 MB TIF)
Figure S13 Anti-RPA antibodies immunoprecipitate both
phospho-RPA and an unmodified form. Immunoprecipitation
analysis was performed using anti-RPA32 antibodies. Cell lysates
were prepared from ATBIVA and 11-4 cells, immediately after
etoposide (VP), or vehicle (Con) exposure, or 30 min (w30) and 2
hours (w2h) after recovery in normal medium. Immunoprecipi-
tates and input (1% of cell lysates) were separated by SDS-PAGE
and blotted with anti-RPA32 antibodies. IP: immunoprecipitation.
WB: western blotting. RPA32-P: phospho-RPA.
Found at: doi:10.1371/journal.pone.0013554.s013 (0.18 MB TIF)
Figure S14 BrdU incorporation after etoposide treatment. (A)
Immunofluorescence staining were performed using cells with or
without etoposide exposure, followed by BrdU labeling for 60 min.
Scale bar: 20 mm. (B) Quantitative analysis of immunoprecipitated
DNA using real-time PCR. Genomic DNA was isolated from cells
with or without etoposide exposure, followed by BrdU labeling for
60 min. 15 mg of sonicated and purified DNA was immunopre-
cipitated by normal IgG or anti-BrdU antibodies.
Found at: doi:10.1371/journal.pone.0013554.s014 (1.58 MB TIF)
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